[Chinese guideline on the diagnosis and management of thrombotic thrombocytopenic purpura (2022)].

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. Validation of Automated Fragmented Red Cell Count by the Sysmex XN-9000: Correlation With Microscopy and Impact of Microcytosis/Hypochromia.International journal of laboratory hematology · 2026
   Article
2. Secondary thrombotic thrombocytopenic purpura following severe infection: a case report.World journal of emergency medicine · 2026
   Article
3. [Caplacizumab combined with therapeutic plasma exchange, glucocorticoids, and rituximab for refractory thrombotic thrombocytopenic purpura: a case report and literature review].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2026
   Review
4. Catastrophic antiphospholipid syndrome following surgery for Libman-Sacks endocarditis: A case report and literature review.Journal of cardiothoracic surgery · 2025
   Review
5. Performance of Large Language Models in Diagnosing Rare Hematologic Diseases and the Impact of Their Diagnostic Outputs on Physicians: Combined Retrospective and Prospective Study.Journal of medical Internet research · 2025
   Article
6. [Explanation and interpretation of blood transfusion provisions for children with hematological diseases in the national health standard "Guideline for pediatric transfusion"].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
   Article
7. [The combined regimen based on obinutuzumab plus glucocorticoid for 4 cases of relapsed iTTP].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2025
   Article
8. Systemic immune inflammation index guides machine learning for rapid TTP diagnosis: a retrospective cohort study.Frontiers in medicine · 2025
   Article
9. [Immune thrombotic thrombocytopenic purpura treated with Obinutuzumab: a case report and literature review].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2024
   Review
10. [Relapsed immune thrombotic thrombocytopenic purpura secondary to systemic lupus erythematosus: a case report and literature review].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2024
    Review
11. Hereditary thrombotic thrombocytopenic purpura mimicking immune thrombocytopenia was revealed by miscarriage-novel compound heterozygous mutations in hTTP.BMC medical genomics · 2024
    Article
12. Stress-induced hyperglycemia is associated with the mortality of thrombotic thrombocytopenic purpura patients.Diabetology & metabolic syndrome · 2024
    Article
13. Acute Hepatitis E Induced the First Episode of Immune-Mediated Thrombotic Thrombocytopenic Purpura: The First Case Report.Infection and drug resistance · 2023
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as